Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;44(10):1361-76.
doi: 10.1007/s40279-014-0217-3.

Vaccination in elite athletes

Affiliations
Review

Vaccination in elite athletes

Barbara C Gärtner et al. Sports Med. 2014 Oct.

Abstract

Public health vaccination guidelines cannot be easily transferred to elite athletes. An enhanced benefit from preventing even mild diseases is obvious but stronger interference from otherwise minor side effects has to be considered as well. Thus, special vaccination guidelines for adult elite athletes are required. In most of them, protection should be strived for against tetanus, diphtheria, pertussis, influenza, hepatitis A, hepatitis B, measles, mumps and varicella. When living or traveling to endemic areas, the athletes should be immune against tick-borne encephalitis, yellow fever, Japanese encephalitis, poliomyelitis, typhoid fever, and meningococcal disease. Vaccination against pneumococci and Haemophilus influenzae type b is only relevant in athletes with certain underlying disorders. Rubella and papillomavirus vaccination might be considered after an individual risk-benefit analysis. Other vaccinations such as cholera, rabies, herpes zoster, and Bacille Calmette-Guérin (BCG) cannot be universally recommended for athletes at present. Only for a very few diseases, a determination of antibody titers is reasonable to avoid unnecessary vaccinations or to control efficacy of an individual's vaccination (especially for measles, mumps, rubella, varicella, hepatitis B and, partly, hepatitis A). Vaccinations should be scheduled in a way that possible side effects are least likely to occur in periods of competition. Typically, vaccinations are well tolerated by elite athletes, and resulting antibody titers are not different from the general population. Side effects might be reduced by an optimal selection of vaccines and an appropriate technique of administration. Very few discipline-specific considerations apply to an athlete's vaccination schedule mainly from the competition and training pattern as well as from the typical geographical distribution of competitive sites.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Poster at US airports (this poster was displayed in Boston) after the 2006 World Cup in Germany, since measles occurred during that time (photo reproduced with permission from Prof. Dr. Martina Sester)

Comment in

Similar articles

Cited by

References

    1. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2012 global summary 2013. http://www.who.int/immunization_monitoring/data/data_subject/en/index.html. Accessed 1 Jun 2013.
    1. Ständige Impfkommission (STIKO). Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epi Bull. 2012;283–10.
    1. European Center for Disease Prevention and Control. Vaccination schedules; 2013. http://www.euvac.net/graphics/euvac/background.html. Accessed 1 Jun 2013.
    1. Centers for Disease Control and Prevention General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60:1–64. - PubMed
    1. Australian Government Department of Health and Aging. The Australian immunisation handbook. 10th ed; 2013.